Correction
Since publication of our article [1], we have noticed that amendments to the second sentence of the "Study Design" section are required as this should read as follows:
"Approved by the local ethics committee, patient enrolment was restricted to the following patients: those aged 18 years and greater and taking immediate release metformin alone or in combination with other oral agents, those excluded had symptoms of poor diabetes control, were pregnant, had serum creatinine levels >1.3 mg/dL (female) or 1.4 mg/dL (male), nephropathy, evidence of hepatic disease or history of alcohol abuse."
We apologize for any inconvenience or confusion that this may have caused.
References
Levy J, Cobas RA, Gomes MB: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2010, 2: 16-10.1186/1758-5996-2-16.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1186/1758-5996-2-16
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Levy, J., Cobas, R.A. & Gomes, M.B. Erratum to: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 2, 57 (2010). https://doi.org/10.1186/1758-5996-2-57
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1758-5996-2-57